Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021

IMPORTANCE: New formulations of prescription drugs can improve convenience and tolerability for patients, but they also constitute manufacturer strategies to extend brand-name drug market exclusivity periods. OBJECTIVE: To examine whether new formulations of brand-name novel drugs were associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Ravi, Morten, Christopher J., Zhu, Angela Y., Ramachandran, Reshma, Shah, Nilay D., Ross, Joseph S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123500/
https://www.ncbi.nlm.nih.gov/pubmed/35977259
http://dx.doi.org/10.1001/jamahealthforum.2022.1096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123500/
https://www.ncbi.nlm.nih.gov/pubmed/35977259
http://dx.doi.org/10.1001/jamahealthforum.2022.1096

Ejemplares similares